Literature DB >> 8766528

Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis.

H Kitamura1, S Yonezawa, S Tanaka, Y S Kim, E Sato.   

Abstract

We examined the expression of carbohydrate antigens which are associated with the earliest steps in mucin glycosylation (Tn and sialosyl-Tn) and the expression of the mucin core protein antigens associated with MUC1 gene product (DF3 antigen) as well as MUC2 gene product (intestinal-MRP antigen) in tissues from 38 patients with carcinoma of the ampulla of Vater, in order to determine whether these mucin antigens are available as tumor markers or not, and to evaluate whether their expression is correlated with the biological behavior of the carcinomas or not. DF3 antigen showed a relatively high expression rate (61%) in the carcinoma tissues, but was rarely expressed in the non-neoplastic epithelium around the carcinomas in the region of the ampulla of Vater. Tn and sialosyl-Tn antigens showed high expression rates in the carcinoma tissues (86% and 84% each), whereas they showed rare or no expression in the non-neoplastic epithelium around the carcinomas, except for highly restricted expression in the duodenal villous epithelium. The patients with positive DF3 expression in the carcinoma showed significantly poorer survival than those with negative DF3 expression (P < 0.05), whereas the patients with positive intestinal-MRP expression in the carcinoma showed significantly more favorable survival than those with negative intestinal-MRP expression (P < 0.05). The expression rate of DF3 antigen was significantly higher in the cases with deep invasion into the pancreas (89%) than in those with no or minimal invasion (52%) (P < 0.05). In contrast, the expression rate of intestinal-MRP antigen was significantly higher in the cases with no or minimal invasion into the pancreas (38%) than in those with deep invasion (0%) (P<0.05). In conclusion, the expression of DF3, To and sialosyl-Tn antigens is an effective histopathological indicator for carcinomas in the area of the ampulla of Vater, and the expression of DF3 and intestinal-MRP antigens is a useful indicator of the prognosis of the patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766528      PMCID: PMC5921137          DOI: 10.1111/j.1349-7006.1996.tb00270.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  31 in total

1.  MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism.

Authors:  N W Toribara; J R Gum; P J Culhane; R E Lagace; J W Hicks; G M Petersen; Y S Kim
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.

Authors:  H Sekine; T Ohno; D W Kufe
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

4.  Clinical value of sialyl Tn antigen in patients with gynecologic tumors.

Authors:  M Inoue; H Ogawa; K Nakanishi; O Tanizawa; K Karino; J Endo
Journal:  Obstet Gynecol       Date:  1990-06       Impact factor: 7.661

5.  Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.

Authors:  Y Tashiro; S Yonezawa; Y S Kim; E Sato
Journal:  Hum Pathol       Date:  1994-04       Impact factor: 3.466

6.  Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.

Authors:  M Osako; S Yonezawa; B Siddiki; J Huang; J J Ho; Y S Kim; E Sato
Journal:  Cancer       Date:  1993-04-01       Impact factor: 6.860

7.  Immunodetection of sialyl-Tn antigen in normal, hyperplastic and cancerous tissues of the uterine endometrium.

Authors:  M Inoue; H Ogawa; O Tanizawa; Y Kobayashi; M Tsujimoto; T Tsujimura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas.

Authors:  T F Orntoft; N Harving; N C Langkilde
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

9.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

10.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

View more
  15 in total

1.  Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Authors:  Fausto Sessa; Daniela Furlan; Clementina Zampatti; Ileana Carnevali; Francesca Franzi; Carlo Capella
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

2.  Precursor lesions of pancreatic cancer.

Authors:  Suguru Yonezawa; Michiyo Higashi; Norishige Yamada; Masamichi Goto
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

3.  Clinicopathological Study of Carcinoma of the Ampulla of Vater with Special Reference to MUC1, MUC2 and MUC5AC Expression.

Authors:  Maithili Mandar Kulkarni; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Aniket Kakade; Lokesh Fegade; Ketan Narkhede
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 4.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

5.  Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis.

Authors:  Ma Jinfeng; Wataru Kimura; Ichiro Hirai; Fumiaki Sakurai; Toshiyuki Moriya; Masaomi Mizutani
Journal:  Int J Gastrointest Cancer       Date:  2003

6.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.

Authors:  Luciana Bertocco de Paiva Haddad; Rosely Antunes Patzina; Sônia Penteado; André Luiz Montagnini; José Eduardo Monteiro da Cunha; Marcel Cerqueira César Machado; José Jukemura
Journal:  J Gastrointest Surg       Date:  2010-01-27       Impact factor: 3.452

Review 8.  MUC1 in carcinoma-host interactions.

Authors:  K Denda-Nagai; T Irimura
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 3.009

9.  Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.

Authors:  Arne Westgaard; Aasa R Schjølberg; Milada Cvancarova; Tor J Eide; Ole Petter F Clausen; Ivar P Gladhaug
Journal:  Histopathology       Date:  2009-02       Impact factor: 5.087

10.  Targeted alpha therapy approach to the management of pancreatic cancer.

Authors:  Barry J Allen; Syed M Abbas Rizvi; Chang F Qu; Ross C Smith
Journal:  Cancers (Basel)       Date:  2011-04-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.